News & Events
Peapod Bio in the news and on the road.
-
SLAS 2026
Visit Peapod Bio at the 2026 SLAS International Conference & Exhibition! February 7-11, 2026 | Boston, MA Booth #1129 Mark your calendars to join our Solution Spotlight presentation and our poster presentation. Solutions Spotlight: Now you see it! High-throughput screening using MALDI MS and polymeric enrichment arrays (PEAs) to visualize the invisible Monday, February 9…
All News & Events
Filter by Type
-
Event
Peapod Bio CEO Zachary Gurard-Levin to present a Webinar November 18, 2025 hosted by Bruker.
Title: The evolution of combining surface chemistry and MALDI mass spectrometry: A powerful foundation for high-throughput screening When: November 18, 2025 at 11:00 am EDT | 8:00 am PDT | 5:00 pm CEST followed by live Q&A. In this webinar hosted by Bruker, Gurard-Levin will discuss the development of different surface chemistries and their applications […]
-
News
Peapod Bio, Inc. launches with innovative assays and drug discovery services
Peapod Bio, Inc., a new contract research organization (CRO), launches to offer small molecule assay development and high-throughput screening (HTS) services using label-free and optical technologies. Our innovative mass spectrometry platform, powered by polymeric enrichment arrays (PEAs) and state-of-the-art MALDI instrumentation, accelerates the characterization of biochemical activities and binding interactions for virtually any target. With […]
-
Event
Meet Peapod Bio CEO in Boston September 23-24 at Discovery on Target 2025!
Peapod Bio Chief Executive Officer and Founder Zachary Gurard-Levin, PhD is attending the Discovery on Target Conference in Boston September 23-24. Click below to schedule a meeting to learn more about Peapod Bio’s innovative assay solutions to accelerate your drug discovery research.
-
News
Tango Biosciences Appoints Zachary Gurard-Levin, PhD to Board of Directors
Tango Biosciences, Inc., the premier contract research organization for custom affinity reagents by phage display, announced the appointment of Zachary Gurard-Levin, PhD, to its board of directors effective immediately. Gurard-Levin brings over two decades of experience in assay development and driving successful research programs for biotech…